Skip to the main content

Professional paper

https://doi.org/10.2478/10004-1254-65-2014-2393

Successful treatment of cardiogenic shock with an intraaortic balloon pump following aluminium phosphide poisoning

Omid Mehrpour ; Atherosclerosis and Coronary Artery Research Center, Birjand University of Medical Sciences, Birjand, Iran
Ahmad Amouzeshi ; Department of Cardiac Surgery, Birjand University of Medical Sciences, Birjand, Iran
Bita Dadpour ; Addiction Research Centre, Mashhad, Iran
Zohreh Oghabian ; Department of Clinical Toxicology, Kerman University of Medical Sciences, Kerman, Iran
Nasim Zamani ; Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Shahram Amini ; Department of Anesthesiology, Mashhad University of Medical Toxicology Sciences, Mashhad, Iran
Robert S. Hoffman ; Division of Medical Toxicology, Department of Emergency Medicine, NYU School of Medicine, Bellevue Hospital Center, NY, USA


Full text: english pdf 1.020 Kb

page 121-126

downloads: 1.025

cite


Abstract

Aluminium phosphide (AlP) is a highly toxic pesticide that inhibits cytochrome oxidase c and causes oxidative stress. Death results from refractory cardiogenic shock due to myocardial dysfunction. There is very little information regarding extracorporeal life support in severe AlP poisoning. Although several therapies are available, none are curative. We report on the use of an intra-aortic balloon pump (IABP) in a 24-year-old woman brought to our hospital after an intentional ingestion of a tablet of AlP (3 g), which caused refractory AlP-induced cardiogenic shock and acute respiratory distress syndrome (ARDS). The patient underwent gastric lavage with potassium permanganate, received sodium bicarbonate intravenously, and was admitted to the intensive care unit. Echocardiography at 36 h post ingestion showed a left ventricular ejection fraction (LVEF) of <20 %. An IABP was inserted and the patient’s vital signs stabilised. After eight days, the IABP was removed and on day 20, the patient’s LVEF increased to 50 %. IABP was successfully used and may improve future prognoses for severely poisoned AlP patients with refractory cardiogenic shock. We encourage clinical toxicologists to examine this new treatment.

Keywords

emergency medical treatment; extracorporeal life support; phosphine gas poisoning

Hrčak ID:

117140

URI

https://hrcak.srce.hr/117140

Publication date:

10.3.2014.

Article data in other languages: croatian

Visits: 2.381 *